Combination adefovir?lamivudine prevents emergence of adefovir resistance in lamivudine-resistant hepatitis B
- 15 August 2007
- journal article
- Published by Wiley in Journal of Gastroenterology and Hepatology
- Vol. 22 (9), 1500-1505
- https://doi.org/10.1111/j.1440-1746.2007.05093.x
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- Treatment options in HBVJournal of Hepatology, 2006
- Increased risk of adefovir resistance in patients with lamivudine-resistant chronic hepatitis B after 48 weeks of adefovir dipivoxil monotherapyHepatology, 2006
- 116 A multicenter italian study of rescue adefovir dipivoxil therapy in lamivudine resistant patients: A 2-year analysis of 650 patientsJournal of Hepatology, 2006
- Virologic response and resistance to adefovir in patients with chronic hepatitis BJournal of Hepatology, 2005
- Chronic hepatitis B: Update of recommendationsHepatology, 2004
- Week 48 resistance surveillance in two phase 3 clinical studies of adefovir dipivoxil for chronic hepatitis BHepatology, 2003
- Prevalence and Clinical Correlates of YMDD Variants during Lamivudine Therapy for Patients with Chronic Hepatitis BClinical Infectious Diseases, 2003
- Adefovir Dipivoxil for the Treatment of Hepatitis B e Antigen–Negative Chronic Hepatitis BNew England Journal of Medicine, 2003
- Adefovir Dipivoxil for the Treatment of Hepatitis B e Antigen–Positive Chronic Hepatitis BNew England Journal of Medicine, 2003
- Resistance surveillance in chronic hepatitis B patients treated with adefovir dipivoxil for up to 60 weeksHepatology, 2002